Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Family history assessment to detect increased risk for colorectal cancer: conceptual considerations and a preliminary economic analysis.

Ramsey SD, Burke W, Pinsky L, Clarke L, Newcomb P, Khoury MJ.

Cancer Epidemiol Biomarkers Prev. 2005 Nov;14(11 Pt 1):2494-500.

2.

A decision-analytic evaluation of the cost-effectiveness of family history-based colorectal cancer screening programs.

Ramsey SD, Wilschut J, Boer R, van Ballegooijen M.

Am J Gastroenterol. 2010 Aug;105(8):1861-9. doi: 10.1038/ajg.2010.185. Epub 2010 May 11.

PMID:
20461066
3.

Cost-effectiveness of screening for colorectal cancer in the general population.

Frazier AL, Colditz GA, Fuchs CS, Kuntz KM.

JAMA. 2000 Oct 18;284(15):1954-61.

PMID:
11035892
4.

Cost-effectiveness of colorectal cancer screening in high-risk Spanish patients: use of a validated model to inform public policy.

Ladabaum U, Ferrandez A, Lanas A.

Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2765-76. doi: 10.1158/1055-9965.EPI-10-0530. Epub 2010 Sep 1.

5.

Cost-effectiveness of screening the average-risk population for colorectal cancer.

Provenzale D.

Gastrointest Endosc Clin N Am. 2002 Jan;12(1):93-109.

PMID:
11916165
6.

Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis.

van Hees F, Habbema JD, Meester RG, Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG.

Ann Intern Med. 2014 Jun 3;160(11):750-9. doi: 10.7326/M13-2263.

7.

Cost-effectiveness of family history-based colorectal cancer screening in Australia.

Ouakrim DA, Boussioutas A, Lockett T, Hopper JL, Jenkins MA.

BMC Cancer. 2014 Apr 16;14:261. doi: 10.1186/1471-2407-14-261.

8.

Impact of comorbidity on colorectal cancer screening cost-effectiveness study in diabetic populations.

Dinh TA, Alperin P, Walter LC, Smith R.

J Gen Intern Med. 2012 Jun;27(6):730-8. doi: 10.1007/s11606-011-1972-6. Epub 2012 Jan 12. Review.

9.

Cost-effectiveness of colonoscopy in screening for colorectal cancer.

Sonnenberg A, Delcò F, Inadomi JM.

Ann Intern Med. 2000 Oct 17;133(8):573-84.

PMID:
11033584
10.
11.

Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening.

Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG, Habbema JD, Kuipers EJ.

J Natl Cancer Inst. 2009 Oct 21;101(20):1412-22. doi: 10.1093/jnci/djp319. Epub 2009 Sep 24.

12.

Cost-effectiveness of computerized tomographic colonography versus colonoscopy for colorectal cancer screening.

Heitman SJ, Manns BJ, Hilsden RJ, Fong A, Dean S, Romagnuolo J.

CMAJ. 2005 Oct 11;173(8):877-81.

14.

Cost-benefit analysis of screening colonoscopy in 40- to 50-year-old first-degree relatives of patients with colorectal cancer.

Menges M, Gärtner B, Georg T, Fischinger J, Zeitz M.

Int J Colorectal Dis. 2006 Sep;21(6):596-601. Epub 2005 Nov 12.

PMID:
16284773
15.

Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer. A cost-effectiveness analysis.

Ladabaum U, Chopra CL, Huang G, Scheiman JM, Chernew ME, Fendrick AM.

Ann Intern Med. 2001 Nov 6;135(9):769-81.

PMID:
11694102
16.

Cost-effectiveness analysis of fecal occult blood screening for colorectal cancer.

Lejeune C, Arveux P, Dancourt V, Béjean S, Bonithon-Kopp C, Faivre J.

Int J Technol Assess Health Care. 2004 Fall;20(4):434-9.

PMID:
15609792
17.
18.

Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer.

Ramsey SD, Clarke L, Etzioni R, Higashi M, Berry K, Urban N.

Ann Intern Med. 2001 Oct 16;135(8 Pt 1):577-88.

PMID:
11601929
19.

Cost effectiveness of colorectal cancer screening in the elderly.

Wagner JL, Herdman RC, Wadhwa S.

Ann Intern Med. 1991 Nov 15;115(10):807-17.

PMID:
1929029
20.

How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer?

Wilschut JA, Steyerberg EW, van Leerdam ME, Lansdorp-Vogelaar I, Habbema JD, van Ballegooijen M.

Cancer. 2011 Sep 15;117(18):4166-74. doi: 10.1002/cncr.26009. Epub 2011 Mar 8.

Supplemental Content

Support Center